Premalignant alteration assessment in liver-like tissue derived from embryonic stem cells by aristolochic acid I exposure.
Premalignant alteration assessment in liver-like tissue derived from embryonic stem cells by aristolochic acid I exposure.
复制标题
马兜铃酸 I 暴露对胚胎干细胞来源的肝样组织的癌前改变评估
DOI:
10.18632/oncotarget.12424
复制
发表时间:
2016-11-29
期刊:
影响因子:
--
通讯作者:
Lou YJ
中科院分区:
文献类型:
--
作者:
Li T;Jin K;Zhu DY;Li L;Mao ZR;Wu BW;Wang YF;Pan ZF;Li LJ;Xiang CS;Su KK;Lou YJ
The in vitro predictive evaluation of chemical carcinogenicity based on hepatic premalignance has so far not been established. Here, we report a novel approach to investigate the premalignant events triggered by human carcinogen aristolochic acid I (AAI) in the liver-like tissue derived from mouse embryonic stem cells. By AAI exposure, the liver-like tissue exhibited the paracrine interleukin-6 phenotypic characteristics. Hepatocytes expressed STAT3/p-STAT3, c-Myc and Lin28B in parallel. Some of them displayed the dedifferentiation characteristics, such as full of α-fetoprotein granules, increase in size, and nucleocytoplasmic shuttle of Oct4. When these cells were injected into mice, the xenografts mostly displayed the uniform area of hepatic-like tissue with malignant nuclei. The hepatic malignant markers, α-fetoprotein, cytokeratin 7 and cytokeratin 19, were co-expressed in albumin-positive areas, respectively. In conclusion, we established an approach to predict the hepatic premalignance triggered by carcinogen AAI. This premalignant assay system might aid to evaluate the effects of potential carcinogens in liver, and probably to screen the protecting against hepatocarcinogenic efficacy of pharmaceuticals in vitro.